Polyglucosamine L112 in Overweight and Obese Subjects
Sponsored by Azienda di Servizi alla Persona di Pavia
About this trial
Last updated 4 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Ended 4 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- weight > 75 Kg
- absence of previous diet therapy attempts
- no fluctuation of at least 3 kg in the previous 3 months
- Beck Depression Inventory score < 20 pt
- Binge Eating Scale score < 27 pt
Exclusion Criteria
- allergy to shellfish
- pregnancy or breast feeding
- presence of cardiopathies, nephropathies, liver diseases, bronchopneumopathies, haemopathies, dermopathies, chronic-degenerative diseases of the Central Nervous System
- presence of active peptic ulcer, ulcerative colitis, Crohn's disease, celiac disease, inflammatory bowel disease
- symptomatic cholelithiasis
- previous or current neoplasms
- epilepsy
- obesity secondary to endocrinopathies or genetic syndromes
- significant motor disability or mental retardation
- major depressive disorder, bulimia, panic disorder, obsessive-compulsive disorder, post-traumatic stress disorder, bipolar disorder (I or II), schizophrenia
- previous history or current diagnosis of drug abuse or alcoholism
- changing in smoking habits or quitting smoking in the last 6 months
- current use or in the last 3 months of psychoactive drugs or current use or in the last 12 months of drugs affecting body weight or appetite